Christos Demosthenous

COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study

Thomas Chatzikonstantinou, Anargyros Kapetanakis, Lydia Scarfò et al. · Leukemia · 2021 · 94 citations · Full text

Medicine, Internal Medicine, Oncology +14

Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma

Christos Demosthenous, Jing Han, Mary Stenson et al. · Oncotarget · 2015 · 32 citations · Full text

Medicine, Oncology, Pharmacology +16

Loss of function mutations in PTPN6 promote STAT3 deregulation<i>via</i>JAK3 kinase in diffuse large B-cell lymphoma

Christos Demosthenous, Jing Han, Guangzhen Hu et al. · Oncotarget · 2015 · 27 citations · Full text

Medicine, Hematology, Oncology +13

Anchimerically Activated ProTides as Inhibitors of Cap-Dependent Translation and Inducers of Chemosensitization in Mantle Cell Lymphoma

Aniekan Okon, Jingjing Han, Surendra Dawadi et al. · Journal of Medicinal Chemistry · 2017 · 27 citations · Full text

Medicine, Oncology, Pharmacology +14

Extramedullary relapse and discordant CD19 expression between bone marrow and extramedullary sites in relapsed acute lymphoblastic leukemia after blinatumomab treatment

Christos Demosthenous, Chrysavgi Lalayanni, Michalis Iskas et al. · Current Problems in Cancer · 2018 · 25 citations

Medicine, Hematology, Oncology +17